Go Pro

Gyre Therapeutics (GYRE) Institutional Ownership

Gyre Therapeutics logo
$7.11 +0.11 (+1.57%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$7.12 +0.01 (+0.14%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Gyre Therapeutics (NASDAQ:GYRE)

Current
Institutional Ownership
Percentage
23.99%
Number of
Institutional Buyers
(last 12 months)
16
Total
Institutional Inflows
(last 12 months)
$8.83M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$751.56K
Get GYRE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Gyre Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

GYRE Institutional Buying and Selling by Quarter

Gyre Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/17/2026Bank of America Corp DE12,525$83K0.0%N/A0.011%
8/7/2026BlackRock Inc.993,943$6.55M0.0%N/A0.892%
8/7/2026Deutsche Bank AG17,939$118K0.0%N/A0.016%
8/6/2026Bank of New York Mellon Corp62,750$414K0.0%N/A0.056%
5/18/2026Royal Bank of Canada5,605$39K0.0%-56.1%0.006%
5/7/2026Dimensional Fund Advisors LP25,268$176K0.0%+131.8%0.026%
5/5/2026Bank of New York Mellon Corp43,144$301K0.0%+4.7%0.044%
2/17/2026State of Wisconsin Investment Board24,800$175K0.0%-36.4%0.026%
2/16/2026Barclays PLC18,531$131K0.0%+38.3%0.019%
2/13/2026Charles Schwab Investment Management Inc.169,158$1.19M0.0%+37.1%0.176%
They didn't warn anyone in 1971. This time someone is warning you. (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
2/13/2026State Street Corp202,225$1.43M0.0%+10.7%0.210%
2/13/2026Wells Fargo & Company MN12,919$91K0.0%+132.4%0.013%
2/12/2026Dimensional Fund Advisors LP10,903$77K0.0%N/A0.011%
2/10/2026Goldman Sachs Group Inc.31,108$220K0.0%+72.5%0.032%
2/9/2026Geode Capital Management LLC423,222$2.99M0.0%+13.0%0.439%
2/3/2026SBI Securities Co. Ltd.162,915$1.15M0.0%-2.9%0.169%
1/1/2026JPMorgan Chase & Co.3,694$28K0.0%-42.8%0.004%
11/17/2025Millennium Management LLC35,751$267K0.0%N/A0.037%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.4,203$31K0.0%-43.3%0.004%
11/17/2025Alliancebernstein L.P.21,830$163K0.0%+9.5%0.023%
11/14/2025Lazard Asset Management LLC14,932$111K0.0%N/A0.016%
11/7/2025JPMorgan Chase & Co.3,694$28K0.0%-42.8%0.004%
11/6/2025Rhumbline Advisers13,432$100K0.0%-17.0%0.014%
11/5/2025SBI Securities Co. Ltd.167,866$1.25M0.0%-27.7%0.174%
10/30/2025Strs Ohio21,100$157K0.0%+58.6%0.022%
10/24/2025State of Alaska Department of Revenue5,219$38K0.0%N/A0.005%
8/15/2025Bank of America Corp DE6,277$46K0.0%+28.8%0.007%
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.7,413$54K0.0%+77.8%0.008%
8/12/2025American Century Companies Inc.11,291$83K0.0%-52.6%0.012%
8/12/2025JPMorgan Chase & Co.6,461$47K0.0%+84.6%0.007%
8/8/2025Geode Capital Management LLC401,709$2.95M0.0%+28.6%0.428%
8/8/2025SBI Securities Co. Ltd.232,299$1.71M0.0%+87.9%0.248%
6/27/2025Goldman Sachs Group Inc.16,147$125K0.0%-38.8%0.017%
5/16/2025Goldman Sachs Group Inc.16,147$125K0.0%-38.8%0.017%
5/14/2025Advantage Alpha Capital Partners LP13,663$105K0.0%+54.0%0.015%
5/13/2025American Century Companies Inc.23,825$184K0.0%N/A0.025%
5/9/2025Charles Schwab Investment Management Inc.111,416$860K0.0%-2.7%0.119%
5/2/2025SBI Securities Co. Ltd.123,629$954K0.0%+22.1%0.132%
4/29/2025Bank of New York Mellon Corp16,492$127K0.0%+18.7%0.018%
4/7/2025GAMMA Investing LLC1,822$140K0.0%+15,083.3%0.002%
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad)

Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel

2/17/2025Bank of America Corp DE6,937$84K0.0%+40.4%0.007%
2/14/2025Northern Trust Corp103,382$1.25M0.0%+9.1%0.111%
2/13/2025Barclays PLC10,543$128K0.0%+13.5%0.011%
2/13/2025Wells Fargo & Company MN4,016$49K0.0%+29.4%0.004%
2/11/2025Advantage Alpha Capital Partners LP8,873$107K0.0%-66.7%0.009%
2/6/2025Charles Schwab Investment Management Inc.114,566$1.39M0.0%+0.8%0.123%
2/6/2025SBI Securities Co. Ltd.101,239$1.23M0.0%N/A0.108%
2/4/2025Bank of New York Mellon Corp13,896$168K0.0%+11.1%0.015%
11/19/2024Barclays PLC9,288$116K0.0%+281.8%0.010%
11/16/2024Geode Capital Management LLC303,647$3.81M0.0%+16.9%0.325%
11/15/2024Barclays PLC9,288$116K0.0%+281.8%0.010%
11/15/2024State Street Corp104,490$1.31M0.0%+8.8%0.112%
11/13/2024FMR LLC3,742$47K0.0%N/A0.004%
11/13/2024Advantage Alpha Capital Partners LP26,634$334K0.1%N/A0.029%
11/12/2024Charles Schwab Investment Management Inc.113,648$1.43M0.0%+392.2%0.122%
8/14/2024Marshall Wace LLP10,720$128K0.0%-58.0%0.013%
8/9/2024Renaissance Technologies LLC13,900$166K0.0%N/A0.016%
8/9/2024WINTON GROUP Ltd18,467$220K0.0%N/A0.022%
8/1/2024Rhumbline Advisers10,291$123K0.0%N/A0.012%
7/26/2024Bank of New York Mellon Corp18,266$218K0.0%N/A0.021%
5/10/2024Vanguard Group Inc.195,098$3.41M0.0%-1.5%0.228%


GYRE Institutional Ownership - Frequently Asked Questions

During the previous two years, 27 institutional investors and hedge funds held shares of Gyre Therapeutics. The most heavily invested institutionals were BlackRock Inc. ($6.55M), Geode Capital Management LLC ($2.99M), State Street Corp ($1.43M), Northern Trust Corp ($1.25M), Charles Schwab Investment Management Inc. ($1.19M), SBI Securities Co. Ltd. ($1.15M), and Bank of New York Mellon Corp ($414K).Learn more on Gyre Therapeutics' institutional investors.

23.99% of Gyre Therapeutics' stock is owned by institutional investors. Learn more on GYRE's institutional investor holdings.

Of the 24 institutional investors that purchased Gyre Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($993.94K), SBI Securities Co. Ltd. ($232.30K), Geode Capital Management LLC ($181.83K), Charles Schwab Investment Management Inc. ($137.25K), Bank of New York Mellon Corp ($68.68K), Millennium Management LLC ($35.75K), and Advantage Alpha Capital Partners LP ($31.42K).

Institutional investors have bought a total of 1,319,384 shares in the last 24 months. This purchase volume represents approximately $8.83M in transactions.

The following institutional investors have sold Gyre Therapeutics stock in the last 24 months: SBI Securities Co. Ltd. ($69.38K), State of Wisconsin Investment Board ($14.20K), Royal Bank of Canada ($7.16K), JPMorgan Chase & Co. ($5.53K), MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. ($3.21K), and Rhumbline Advisers ($2.75K).

Institutional investors have sold a total of 102,242 shares in the last 24 months. This volume of shares sold represents approximately $751.56K in transactions.



Institutional ownership data for NASDAQ:GYRE is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/17/2026. New 13F filings are added each quarter as they're published.
From Our Partners